There is no fixing this fundamentally broken POS. This one is dead. New indication? Great, where is the money to finance it? Oh right, it doesn't exist.
Big briggin deal! So what , this is great news to me, no more Glaxo reps to compete with. It's still dha
Anyone who thinks this is no big deal is as crazy as Joe Z and Bill. We are toast. We are not a establish player in the market and we will not be able to sell against a generic Lovaza. We need to all jump ship before it sinks.
you pussy. you sound more like GSK to me. read the data
you pussy. you sound more like GSK to me. read the data
Teva? They don't even have a ANDA approved. And by the way, why is another generic a problem? We have been competing against generic fenofibrates and in a generic market for a long time.
Teva? They don't even have a ANDA approved. And by the way, why is another generic a problem? We have been competing against generic fenofibrates and in a generic market for a long time.